Checkpoint Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.103 million compared to USD 0.192 million a year ago. Net loss was USD 51.85 million compared to USD 62.62 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | +5.62% | +25.33% | -17.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.90% | 67.09M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- CKPT Stock
- News Checkpoint Therapeutics, Inc.
- Checkpoint Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023